Pain management modalities for hidradenitis suppurativa: a patient survey
Name:
Manuscript_HS_Pain_Management_ ...
Size:
297.3Kb
Format:
PDF
Description:
Final Accepted Manuscript
Author
Fernandez, Jennifer MThompson, Alyssa M
Borgstrom, Mark
Orenstein, Lauren A V
Hsiao, Jennifer L
Shi, Vivian Y
Affiliation
Univ Arizona, Coll MedUniv Arizona, Univ Informat Technol Serv
Issue Date
2020-09-20
Metadata
Show full item recordPublisher
TAYLOR & FRANCIS LTDCitation
Jennifer M. Fernandez, Alyssa M. Thompson, Mark Borgstrom, Lauren A. V. Orenstein, Jennifer L. Hsiao & Vivian Y. Shi (2020) Pain management modalities for hidradenitis suppurativa: a patient survey, Journal of Dermatological Treatment, DOI: 10.1080/09546634.2020.1822501Rights
Copyright © 2020 Informa UK Limited.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background Pain is one of the most common and debilitating symptoms of hidradenitis suppurativa (HS). Objective We sought to identify pain management therapies used in HS and assess patient-perceived effectiveness. Methods An anonymous online survey was posted to Facebook HS support groups. Participants selected all that applied from a list of 20 therapies to indicate which ones they have tried for HS pain. For each therapy used, participants were asked to rate effectiveness on a 5-point scale: not successful (1), mildly successful (2), moderately successful (3), very successful (4), and extremely successful (5). Mean effectiveness ratings were calculated by averaging the corresponding numbers. Results Of the 438 participants, 93.8% were female. Participants classified themselves as Hurley stage I (8.2%), II (53.4%), and III (38.4%). Warm compresses were the most commonly used therapy (82.4%), followed by ibuprofen/naproxen (74.7%), Epsom salt baths (57.8%), cold compresses (45.4%), and acetaminophen (44.7%). Marijuana smoking received the highest mean effectiveness rating (2.92 +/- 1.10), followed by marijuana edibles (2.87 +/- 1.10), and opioids (2.83 +/- 0.98). Mean effectiveness ratings were lowest for bleach baths (1.52 +/- 0.80), sitz baths (1.53 +/- 0.56), massage (1.61 +/- 0.92), gabapentin (1.64 +/- 0.73), and acetaminophen (1.71 +/- 0.75). Conclusions and relevance Even the highest-rated pain management modalities are considered only moderately effective by HS patients.Note
12 month embargo; published online 20 September 2020ISSN
0954-6634EISSN
1471-1753PubMed ID
32914659Version
Final accepted manuscriptae974a485f413a2113503eed53cd6c53
10.1080/09546634.2020.1822501
Scopus Count
Collections
Related articles
- Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
- Authors: Lovrić I, Brkić J, Ćorluka M, Čović M, Pejić J, Zeljko Penavić J
- Issue date: 2021 Jul
- The Influence of Pain on Reduced Quality of Life in Patients with Hidradenitis Suppurativa: A Single-Center Retrospective Study.
- Authors: Li Y, Speck P, Viera E, Siira M, Orenstein LAV
- Issue date: 2023
- Understanding Hurley Stage III Hidradenitis Suppurativa Patients' Experiences With Pain: A Cross-Sectional Analysis.
- Authors: Johnston L, Dupuis E, Lam L, Poelman S
- Issue date: 2023 Sep-Oct
- Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
- Authors: Ravn Jørgensen AH, Yao Y, Thomsen SF, Christian Ring H
- Issue date: 2021 Feb
- Patient perspectives of wound care management in hidradenitis suppurativa.
- Authors: Poondru S, Scott K, Riley JM
- Issue date: 2023 Aug